This inventor holds 9 USPTO granted patents. Top assignees: Chai-Tech Corporation, Redox Pharmaceutical Corporation. Active years: 1989-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Haifa, IL (1989)
- Kiyot Tivon, IL (1992)
- Kiyat-Tavon, IL (1995)
- Kiryat Tavon, IL (1996)
- Kiryat Tivon, IL (1991 - 1999)
Company Filing History:
Years Active: 1989-1999
Title: David Gershon: Innovator in Cyanide Treatment
Introduction
David Gershon is a notable inventor based in Kiryat Tivon, Israel. He has made significant contributions to the field of medical treatments, particularly in methods for addressing cyanide poisoning. With a total of 9 patents to his name, Gershon's work has the potential to save lives and improve health outcomes.
Latest Patents
Gershon's latest patents include innovative methods for treating cyanide poisoning. One of his patents describes a method of treating an animal suffering from cyanide exposure. This method involves administering a compound that effectively alleviates undesirable symptoms associated with cyanide toxicity. The compound is characterized by a specific chemical structure, where R¹ and R¹' can be various alkyl or phenyl groups. Another patent outlines a similar method for treating human subjects, emphasizing the importance of effective treatment in cases of cyanide poisoning.
Career Highlights
Throughout his career, David Gershon has worked with several companies, including Chai-Tech Corporation and Redox Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to medical treatments.
Collaborations
Gershon has collaborated with notable colleagues such as Zvi Dori and Uri Taitelman. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Gershon's contributions to the field of cyanide treatment exemplify the impact of innovation in medicine. His patents reflect a commitment to improving health outcomes and addressing critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile